
Melissa S. Mercier
Examiner (ID: 7940, Phone: (571)272-9039 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1468 |
| Issued Applications | 927 |
| Pending Applications | 157 |
| Abandoned Applications | 432 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18909345
[patent_doc_number] => 11872308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Dry powder formulations of epinephrine and associated methods
[patent_app_type] => utility
[patent_app_number] => 18/128705
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 132
[patent_no_of_words] => 46535
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128705 | Dry powder formulations of epinephrine and associated methods | Mar 29, 2023 | Issued |
Array
(
[id] => 18535897
[patent_doc_number] => 20230240983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/192404
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192404 | Dry powder formulations of epinephrine and associated methods | Mar 28, 2023 | Issued |
Array
(
[id] => 18535897
[patent_doc_number] => 20230240983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/192404
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192404 | Dry powder formulations of epinephrine and associated methods | Mar 28, 2023 | Issued |
Array
(
[id] => 18496104
[patent_doc_number] => 20230218647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => BORTEZOMIB COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/188384
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188384
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188384 | Bortezomib compositions | Mar 21, 2023 | Issued |
Array
(
[id] => 18747087
[patent_doc_number] => 11806378
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-07
[patent_title] => Therapeutic composition including phenolic compounds derived from Opuntia littoralis
[patent_app_type] => utility
[patent_app_number] => 18/125106
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3315
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18125106
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/125106 | Therapeutic composition including phenolic compounds derived from Opuntia littoralis | Mar 21, 2023 | Issued |
Array
(
[id] => 20385383
[patent_doc_number] => 12485092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Composition for promoting drug release of drug-delivery liposomes
[patent_app_type] => utility
[patent_app_number] => 18/122284
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 6962
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122284 | Composition for promoting drug release of drug-delivery liposomes | Mar 15, 2023 | Issued |
Array
(
[id] => 20385383
[patent_doc_number] => 12485092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Composition for promoting drug release of drug-delivery liposomes
[patent_app_type] => utility
[patent_app_number] => 18/122284
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 6962
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122284 | Composition for promoting drug release of drug-delivery liposomes | Mar 15, 2023 | Issued |
Array
(
[id] => 20144001
[patent_doc_number] => 12378329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Zwitterionically modified polymers and hydrogels
[patent_app_type] => utility
[patent_app_number] => 18/122416
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 16401
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122416 | Zwitterionically modified polymers and hydrogels | Mar 15, 2023 | Issued |
Array
(
[id] => 18672868
[patent_doc_number] => 20230310314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/175442
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175442
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175442 | MUCOADHESIVE COMPOSITIONS FOR DIRECTIONAL DELIVERY OF ACTIVE AGENTS | Feb 26, 2023 | Abandoned |
Array
(
[id] => 19700103
[patent_doc_number] => 12194102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
[patent_app_type] => utility
[patent_app_number] => 18/175020
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7333
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175020
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175020 | Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances | Feb 26, 2023 | Issued |
Array
(
[id] => 19310397
[patent_doc_number] => 12036191
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-16
[patent_title] => Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
[patent_app_type] => utility
[patent_app_number] => 18/169571
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7711
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169571 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | Feb 14, 2023 | Issued |
Array
(
[id] => 19674589
[patent_doc_number] => 12186427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Fulvestrant formulations and methods of their use
[patent_app_type] => utility
[patent_app_number] => 18/109421
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 35526
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109421 | Fulvestrant formulations and methods of their use | Feb 13, 2023 | Issued |
Array
(
[id] => 18800078
[patent_doc_number] => 11833224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-05
[patent_title] => Lyoprotectant compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/166416
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 8286
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166416 | Lyoprotectant compositions and uses thereof | Feb 7, 2023 | Issued |
Array
(
[id] => 18656055
[patent_doc_number] => 20230301921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => Encased Tamper Resistant Controlled Release Dosage Forms
[patent_app_type] => utility
[patent_app_number] => 18/096686
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096686 | Encased tamper resistant controlled release dosage forms | Jan 12, 2023 | Issued |
Array
(
[id] => 18610812
[patent_doc_number] => 20230277542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
[patent_app_type] => utility
[patent_app_number] => 18/153528
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153528 | Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile | Jan 11, 2023 | Abandoned |
Array
(
[id] => 18418362
[patent_doc_number] => 20230172820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Compositions Containing Microcapsules
[patent_app_type] => utility
[patent_app_number] => 18/150292
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150292 | Compositions containing microcapsules | Jan 4, 2023 | Issued |
Array
(
[id] => 18418362
[patent_doc_number] => 20230172820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Compositions Containing Microcapsules
[patent_app_type] => utility
[patent_app_number] => 18/150292
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150292 | Compositions containing microcapsules | Jan 4, 2023 | Issued |
Array
(
[id] => 19883093
[patent_doc_number] => 12268777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Compositions and methods for treating eosinophilic disorders
[patent_app_type] => utility
[patent_app_number] => 18/150152
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 30
[patent_no_of_words] => 16162
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150152 | Compositions and methods for treating eosinophilic disorders | Jan 3, 2023 | Issued |
Array
(
[id] => 18483465
[patent_doc_number] => 20230210760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Skincare Composition and Process for Creating Sulforaphane
[patent_app_type] => utility
[patent_app_number] => 18/148756
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148756
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148756 | Skincare Composition and Process for Creating Sulforaphane | Dec 29, 2022 | Pending |
Array
(
[id] => 18346991
[patent_doc_number] => 20230135101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/146022
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146022 | BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE | Dec 22, 2022 | Abandoned |